26 College Hill Freemans Bay
Wishing you a wonderful festive period. We will be away from the 24th Dec 22 to 15th Jan 2023.
Sapphire Appearance Medicine Clinic is Auckland's leading non-surgical cosmetic clinic specialising in bringing out the beauty in your skin. We are particularly well known for our specialised Botox®
( Botulinum Toxin Type A or Onabotulinumtoxin A ) treatments, hair transplantation and hair implantation with Hairstetics, fat freezing, fat dissolving now using Belkyra®, as well as catering for the popular anti-wrinkle properties of Botox® used for frown lines and crows feet. Dr Garsing Wong is the first New Zealand born and New Zealand trained physician to offer hair transplantation in New Zealand. The New Zealand Hair Transplantation Institute is co-located in Sapphire. To book your Hair Consultation, please call 09 360 1250. The exclusive purpose built surgical suite is located above Cafe 28 in Auckland Central Medical and Health Centre.
We often combine our Botox® with hyalurone dermal fillers such as Restylane® Perlane rebranded to Restylane Lyft®, Teoxane Teosyal Ultimate®, Global Action®, Ultra Deep® and Redensity II®, and collagen stimulating therapies such as Sculptra® and PRP ( Platelet Rich Plasma therapy or so called Dracula Therapy) and Light Based Therapies such as Laser and Intense Pulse Light Therapy and the Venus Viva® Radiofrequency Treatment thereby giving our patients a comprehensive range of non-invasive techniques to give you natural looking results to beat the signs of aging skin. We have imported the first Cooltech® Cocoon Cryolipolysis Fat Freezing Device in New Zealand, which can target small areas of fat removal with 6 different sized probes.
Meet The Team
Dr Garsing Wong
DR. Garsing WONG, Registered medical practitioner in New Zealand, United Kingdom and Switzerland. Born in Auckland, graduated from the University of Auckland with Bachelor of Medicine and Surgery 1991, Bachelor of Human Biology 1987, Advanced Certificate in the Principles and Practices of Radiochemistry 1987 and the Diploma in Community Emergency Medicine 1996 as well as completing the Laser Training Course, University of Queensland 2005. The first New Zealand born and trained physician to offer hair transplantation.
Member of the World FUE Institute - Hair Transplantation Institute, Belgium.
Associate Member of the International Society of Hair Restoration Surgery, Chicago, USA.
Honorary Clinical Lecturer - Department of General Practice and Primary Health Care, Faculty of Medical and Health Sciences, University of Auckland.
Fellow of the New Zealand College of Appearance Medicine, Fellow of the College of Urgent Care Physicians (formerly known as the Accident and Medical Practitioners Association), Fellow of the Royal New Zealand College of General Practitioners, Member of the International Hyperhidrosis Society. Registered with New Zealand Medical Council and the General Medical Council, United Kingdom.
Examiner for the Royal New Zealand College of Urgent Care Physicians - Urgent Care Physicians Exam since 2006
Committee Member of the Clinical Effectiveness Group, Auckland Primary Health Organisation since 2017
Former Censor for the New Zealand College of Appearance Medicine 2012-2013
Former Secretary and Treasurer of the New Zealand College of Appearance Medicine 2010-2012
Former Chairman of the Royal New Zealand College of Urgent Care Physicians (prev. known as The Accident and Medical Practitioners Association)
Former Medical Director of West Auckland White Cross Accident and Medical Clinic, Henderson, Auckland.
Former Professional Member of the International Association for Organotherapy and Stem Cell Transplantation, Switzerland
Former Member of the Primary Care Advisory Group - Ministry of Social Development New Zealand 2007-2012
Former Member of the Network Lipolysis
Former Associate Member of the Australasian College of Phlebology
Former Medical Director of the White Cross West Auckland Accident and Medical Clinic 1996-1999
Worked in Worthing, Southlands, Orpington and Medway Hospital in England, United Kingdom. General Surgery and General Medicine in Regionalspital Thun, Switzerland.
Languages spoken: English, German, Cantonese, Mandarin.
(Margaret) Wen-Pei CHEN, Born in Taiwan, graduated from the University of Auckland with Bachelor of Science 1993, and Doctor of Medicine 1999 from The Peking Union Medical College, Beijing. Thesis completed on Malaria Vaccine Research. Laser Training Course, University of Queensland 2005. Member of the New Zealand Cosmetic Toiletry and Fragrance Association trading as Cosmetic New Zealand.
Past Position: Former Professional Member of the International Association for Organotherapy and Stem Cell Transplantation, Switzerland. Former Executive Member of the New Zealand Cosmetic Toiletry and Fragrance Association trading as Cosmetic New Zealand.
Languages spoken: English, Mandarin, Taiwanese.
Margaret regularly attends international cosmetic and appearance medicine conferences together with Dr Garsing Wong. Margaret Chen is the first person in New Zealand to gain experience in treating acne scarring, skin resurfacing and wrinkle reduction using the Palomar Non-Ablative Fractional 1540nM Erbium:Glass laser and the first to offer the innovative Venus Viva Nanofractional Ablative Radiofrequency device together with the Venus Viva Diamond Polar skin tightening device. Together with Dr Garsing Wong, Margaret Chen has given workshops for Dermatologist and Plastic Surgeons at the 6th Anti-Aging Symposium in Taiwan, October 2007.
Margaret has formulated her own advanced skin care range Monalinda which is showcased in her new Fat Freezing Clinic - Coolbody, assisted by Yvonne Marvin, personal trainer.
Updated 25th January 2022.
Mind Food 23/Sep/2010
My Wedding Summer 2010/11 Nonsurgical Breast Enhancement
Phosphatidylcholine & Botox Facial Shaping published in the Journal of Cosmetic Dermatology
MANDATORY STATEMENTS :
Cosmetic Medicine Brands. Full Consumer Print Mandatories.
1.Botox® is a prescription medicine for the treatment of frown lines , horizontal forehead lines and crow’s feet round the eyes. Botox® has risks and benefits. Ask your doctor if Botox is right for you. If you have side effects, see your doctor. You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz . Botox® treatment lasts about 4 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. (contains botulinum toxin A 50,100 & 200 units) Allergan (NZ) Limited, Auckland.
2. Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a nonresorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland
3.Sculptra® is a poly-L-lactic acid implant liquid that is injected by a healthcare professional into or below the skin to increase volume of depressed areas, particularly to correct skin depressions. Class III Medical Device. Sculptra® may also be used for large volume restoration and/or correction of the signs of facial fat loss. Sculptra has risks and benefits. Sculptra® treatment may result in injection site reactions and pain. Ask your healthcare professional to explain the range of possible side effects and tell them if any side effects concern you. Sculptra® should not be injected into skin that is inflamed or infected. Exposure to excessive sunlight or UV lamp exposure should be avoided until redness or swelling has resolved. Sculptra® is not recommended for people taking blood thinning medicines and has not been tested in pregnant or breast-feeding women or those aged under 18 years. Lasts for 12-25 months ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma Australia, Sydney. Distributed by Healthcare Logistics Auckland.
4. BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching /discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years. Allergan New Zealand Limited, Auckland.
5. TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ® , TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP TEOSYAL KISS® , RHA KISS® , TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, , TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride They are class III medical devices. Caution for people on blood thinning medicines. Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in skin and hair, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke. Lasts 9 -12 months. Please consult your doctor pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.